Table
5: Subgroups of patients with brain tumours and
the corresponding Glu concentrations in CSF. Values
are expressed in μΜ
CSF |
Glioma Glu concentration (mean ± SE μΜ) |
Meningioma Glu concentration (mean ± SE μΜ) |
|
|
Glu Concentration (N of patients) |
64.2 ± 18.7 (N = 6) |
22.4 ± 7.12 (N = 7) |
(p = 09431) |
|||
Age |
≤ 65
years old > 65 years
old (N of
patients) |
80.35 ± 54.00 (N = 2) 56.13 ± 17.99 (N = 4) |
25.73 ± 9.150 (N = 5) 61.72 ± 48.16 (N = 2) |
Sex |
Female Male (p) |
87.4 ± 31.7 (N = 3) 41.0 ± 14.3 (N = 3) (0.1904) |
16.7 ± 5.1 (N = 6) 56.45 (N = 1) (0.036) |
Grade (WHO 2007) (p) |
II 26.35 (N = 1) III 51.6 ±
24.6 (N = 3) IV 102 ± 32.4
(N=2) (III vs II : 0.3865) |
I 16.70 ± 5.07 (N = 6) II 56.45 ± 0 (N = 1) (0.036) |
|
Tumor volume ≤ 25 cc > 25 cc |
76.78 ± 31.38 (N = 5) 100.875 ± 0.0
(N = 1) |
21.67 ± 7.497 (N = 3) 49.76 ± 28.46 (N = 4) |
|
Mass Effect Yes No (p) |
56.1 ± 18.0 (N = 4) 80.4 ± 54.0 (N = 2) (1.0) |
24.3 ± 9.6 (N
= 5) 17.7 ± 11.0
(N = 2) (0.8465) |
|
Mean time of operation
from first symptom ≤ 90 days > 90 days |
26.70 ± 0.35 (N = 2) 65.83 ± 21.43 (N = 3) |
80.77 ± 39.02 (N = 2) 10.47 ± 5.045 (N = 4) |
|
Seizures Yes No (p) |
56.9 ± 21.1 (N = 5) 100.9 ± 0.0 (N = 1) (0.584) |
6.7 ± 0.0 (N =
1) 24.9 ± 7.8 (N = 6) (0.025) |
|
Ki67 (p) |
≤ 15% 56.0 ± 18.1 (N = 4) > 15% 80.7 ± 53.7 (N = 2) (0.817) |
≤ 5% 55.7 ± 34.2 (N = 4) > 5% 22.8 ± 12.3 (N = 3) (0.3123) |
|
Survival |
≤ 1 year 85.26 ± 15.61 (N = 2) > 1 year 26.78
± 0.2186 (N = 3) |
≤ 2 years 4.695 ± (N = 2) > 2 years 35.02 ± 7.204 (N = 4) |